Key Insights

Highlights

Success Rate

89% trial completion (above average)

Research Maturity

51 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.5%

6 terminated out of 109 trials

Success Rate

89.5%

+3.0% vs benchmark

Late-Stage Pipeline

19%

21 trials in Phase 3/4

Results Transparency

18%

9 of 51 completed with results

Key Signals

9 with results89% success

Data Visualizations

Phase Distribution

76Total
Not Applicable (19)
P 1 (9)
P 2 (27)
P 3 (9)
P 4 (12)

Trial Status

Completed51
Unknown28
Recruiting12
Terminated6
Not Yet Recruiting4
Active Not Recruiting4

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 51 completed trials

Clinical Trials (109)

Showing 20 of 20 trials
NCT06466135Phase 2RecruitingPrimary

Study of WAL0921 in Patients With Glomerular Kidney Diseases

NCT05638880Phase 2CompletedPrimary

Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

NCT05718375Phase 2CompletedPrimary

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

NCT06217302Phase 3RecruitingPrimary

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

NCT05282680Active Not Recruiting

The Hong Kong Diabetes Biobank

NCT07435480Not Yet RecruitingPrimary

Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

NCT07444203RecruitingPrimary

Transformative Research in Diabetic Nephropathy 2.0

NCT02986984RecruitingPrimary

Transformative Research in Diabetic Nephropathy

NCT04929379Phase 2Active Not RecruitingPrimary

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

NCT07022418Phase 2RecruitingPrimary

Formoterol in Diabetes

NCT03325322Phase 2Suspended

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

NCT01320345Phase 3Active Not Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

NCT03620773Phase 1Completed

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

NCT05357742Not ApplicableCompletedPrimary

Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease

NCT04916132Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

NCT06884462Not ApplicableCompletedPrimary

Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients

NCT07187713Phase 4Recruiting

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

NCT03840343Phase 1Terminated

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

NCT07010250Not Yet Recruiting

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

NCT04869761Phase 1Completed

Stem Cell Therapy for Chronic Kidney Disease

Scroll to load more

Research Network

Activity Timeline